Sputnik V, the Russian vaccine candidate for Covid-19, will undergo phase-III clinical trials in India. Dr. Reddy's Laboratories Ltd, a pharmaceutical company headquartered in the southern city of Hyderabad, has partnered with the Russian Direct Investment Fund, a sovereign wealth fund, to conduct